Presynaptic effects of tetrahydropapaveroline on striatal dopaminergic neurons.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001590:Benztropine / Q000494:pharmacology; D001971:Bromocriptine / Q000494:pharmacology; D002421:Caudate Nucleus / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D010208:Papaverine / Q000031:analogs & derivatives*; D011699:Putamen / Q000187:drug effects* / Q000378:metabolism; D011817:Rabbits; D013569:Synapses; D013765:Tetrahydropapaveroline / Q000494:pharmacology*
D001590:Benztropine; D001971:Bromocriptine; D013765:Tetrahydropapaveroline; D010208:Papaverine; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine